Stocks

The table gives an overview of all stocks, alphabetically sorted.
 C Security CSEC Apr 15, 2021 0.36 -6.94   
 C-RAD B CRADB Apr 15, 2021 56.50 +1.99   
 Cadeler AS CADLRO Apr 15, 2021 24.70 0.00   
 CAG Group CAG Apr 15, 2021 74.60 -0.27   
 Calliditas Therapeutics CALTX Apr 15, 2021 116.00 +0.87   
 Calmark B CALMAB Apr 15, 2021 12.46 +15.37   
 Camurus CAMX Apr 15, 2021 206.00 +0.49   
 Cantargia CANTA Apr 15, 2021 33.32 +3.87   
 Capacent Holding CAPAC Apr 15, 2021 53.40 -0.37   
 Carasent CARAO Apr 15, 2021 41.85 0.00   
 Carbiotix CRBX Apr 15, 2021 12.50 -1.96   
 Castellum CAST Apr 15, 2021 204.50 -0.10   
 Catella A CATA Apr 15, 2021 29.80 0.00   
 Catella B CATB Apr 15, 2021 30.70 +4.42   
 Catena CATE Apr 15, 2021 419.20 +4.18   
 Catena Media CTM Apr 15, 2021 56.46 -1.12   
 Cavotec SA CCC Apr 15, 2021 24.40 +2.52   
 CDON CDON Apr 15, 2021 655.50 +7.28   
 Cell Impact B CIB Apr 15, 2021 46.96 -4.36   
 CellaVision CEVI Apr 15, 2021 356.00 +3.31   
 CELLINK B CLNKB Apr 15, 2021 523.50 +6.40   
 Cereno Scientific B CRNOB Apr 15, 2021 2.18 +5.06   
 Cessatech CESSA Apr 15, 2021 16.68 +1.34   
 CGit B CGITB Apr 15, 2021 55.80 +3.33   
 Chordate Medical Holding CMH Apr 15, 2021 0.73 -4.18   
 Christian Berner Tech Trade B CBTTB Apr 15, 2021 37.60 +5.62   
 ChromoGenics CHRO Apr 15, 2021 8.81 -1.34   
 Cibus Nordic Real Estate CIBUS Apr 15, 2021 172.60 -0.80   
 Cint Group CINT Apr 15, 2021 83.20 0.00   
 CirChem CIRCHE Apr 15, 2021 17.00 -1.16   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK